Recruiting Pulmonary Hypertension Studies in Camperdown
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
The safety run-in part of the study aims to evaluate the safety and tolerability of blinatumomab alternating with low-intensity chemotherapy. The phase 3 part of the study aims to compare event-free s...
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
Researchers are looking for other ways to treat pulmonary arterial hypertension (PAH). Sotatercept is a study medicine that is designed to treat PAH. A past study, MK-7962-024 (LIGHTRAY) (NCT06664801...
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112â„¢ in subjects with relapsed or refractory B-cell malignancies....
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
This trial will compare tisagenlecleucel to standard of care in adult participants with relapsed or refractory (r/r) follicular lymphoma....
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
The purpose of this study is to assess the risk of bleeding due to failure of expected pharmacological action of CSL222 in adults with severe or moderately severe hemophilia B with detectable pretreat...
About Pulmonary Hypertension Clinical Trials in Camperdown
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 5 pulmonary hypertension clinical trials recruiting participants in Camperdown, NEW%20SOUTH%20WALES. These studies are seeking a combined 677 participants. Research is being sponsored by Amgen, Merck Sharp & Dohme LLC, CRISPR Therapeutics AG and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Camperdown — FAQ
Are there pulmonary hypertension clinical trials in Camperdown?
Yes, there are 5 pulmonary hypertension clinical trials currently recruiting in Camperdown, NEW%20SOUTH%20WALES. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Camperdown?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Camperdown research site will contact you about next steps.
Are clinical trials in Camperdown free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Camperdown studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 5 active trials in Camperdown are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov